Inhibition of Bcl-xl showed a significant (P = 0.0055) decrease in tumor growth compared to control or doxorubicin treated rats (Fig. 3c), however no difference was observed when A-115463 was combined with doxorubicin, indicating that single Bcl-xl inhibition is more effective. This evidence concerns the gene BCL2L1 and neoplasm.